TETRAPHASE PHARMACEUTICALS I's ticker is and the CUSIP is 88165N905. A total of 3 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $11,000 | -56.0% | 8,400 | -61.5% | 0.00% | – |
| Q4 2018 | $25,000 | -98.1% | 21,800 | -95.5% | 0.00% | -100.0% |
| Q3 2018 | $1,334,000 | +2240.4% | 483,400 | +2921.2% | 0.01% | – |
| Q2 2018 | $57,000 | +90.0% | 16,000 | +64.9% | 0.00% | – |
| Q1 2018 | $30,000 | -81.2% | 9,700 | -61.8% | 0.00% | -100.0% |
| Q4 2017 | $160,000 | -46.7% | 25,400 | -42.1% | 0.00% | -66.7% |
| Q3 2017 | $300,000 | -62.1% | 43,900 | -60.5% | 0.00% | -62.5% |
| Q2 2017 | $792,000 | +159.7% | 111,100 | +234.6% | 0.01% | +100.0% |
| Q1 2017 | $305,000 | +548.9% | 33,200 | +186.2% | 0.00% | – |
| Q4 2016 | $47,000 | +213.3% | 11,600 | +190.0% | 0.00% | – |
| Q3 2016 | $15,000 | -66.7% | 4,000 | -61.9% | 0.00% | -100.0% |
| Q2 2016 | $45,000 | -92.6% | 10,500 | -92.0% | 0.00% | -88.9% |
| Q1 2016 | $606,000 | -52.3% | 130,800 | +3.3% | 0.01% | -40.0% |
| Q4 2015 | $1,270,000 | -36.1% | 126,600 | -52.5% | 0.02% | -44.4% |
| Q3 2015 | $1,988,000 | +142.1% | 266,500 | +1440.5% | 0.03% | +145.5% |
| Q2 2015 | $821,000 | +356.1% | 17,300 | +253.1% | 0.01% | +266.7% |
| Q1 2015 | $180,000 | -73.0% | 4,900 | -70.8% | 0.00% | -70.0% |
| Q4 2014 | $667,000 | -35.4% | 16,800 | -67.6% | 0.01% | -37.5% |
| Q3 2014 | $1,033,000 | +353.1% | 51,800 | +206.5% | 0.02% | +300.0% |
| Q2 2014 | $228,000 | +2180.0% | 16,900 | +1777.8% | 0.00% | – |
| Q1 2014 | $10,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 712 | $0 | 0.00% |